Literature DB >> 19443721

Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.

Anupam Basu1, Gina Menicucci, Joann Maestas, Arup Das, Paul McGuire.   

Abstract

PURPOSE: Angiogenesis, or the formation of new retinal blood vessels, is a key feature of many proliferative retinal diseases including diabetic retinopathy, retinal vein occlusion, and retinopathy of prematurity. The aim of the present study was to investigate the role of the serine proteinase inhibitor plasminogen activator inhibitor -1 (PAI-1) in facilitating retinal angiogenesis.
METHODS: The temporal expression of PAI-1 was examined by real-time PCR, Western blot analysis, and immunohistochemistry in retinal tissues from mice with oxygen-induced retinopathy. The requirement for PAI-1 in facilitating the retinal angiogenic response in this model was examined by quantitating the angiogenic response with wild-type and PAI-1 null mice. The mechanism by which PAI-1 mediates angiogenesis was further investigated with isolated human retinal vascular endothelial cells.
RESULTS: PAI-1 expression was upregulated in the retinas of mice with oxygen-induced retinopathy, which coincided with a significant increase in the expression of vitronectin in the retina of the experimental mice. There was significant reduction in the angiogenic response of PAI-1(-/-) mice compared with wild-type mice. PAI-1 promotes endothelial cell migration in vitro and facilitates the migration of cells on a vitronectin substrate by regulating alpha v integrin cell surface expression.
CONCLUSIONS: These observations suggest a role for PAI-1 during retinal angiogenesis and point to a potential new therapeutic target in the prevention or treatment of retinal neovascularization seen in many ocular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443721      PMCID: PMC3684946          DOI: 10.1167/iovs.09-3619

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  42 in total

1.  Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1.

Authors:  S Stefansson; E Petitclerc; M K Wong; G A McMahon; P C Brooks; D A Lawrence
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

2.  Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis.

Authors:  Marcus Fruttiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

4.  Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.

Authors:  G A McMahon; E Petitclerc; S Stefansson; E Smith; M K Wong; R J Westrick; D Ginsburg; P C Brooks; D A Lawrence
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

5.  Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

Authors:  M V Carriero; S Del Vecchio; M Capozzoli; P Franco; L Fontana; A Zannetti; G Botti; G D'Aiuto; M Salvatore; M P Stoppelli
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

6.  Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

Authors:  V Lambert; C Munaut; A Noël; F Frankenne; K Bajou; R Gerard; P Carmeliet; M P Defresne; J M Foidart; J M Rakic
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 7.  Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

Authors:  M S Pepper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

Review 8.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

Authors:  Maud Jost; Catherine Maillard; Julie Lecomte; Vincent Lambert; Marc Tjwa; Pierre Blaise; Maria-Luz Alvarez Gonzalez; Khalid Bajou; Silvia Blacher; Patrick Motte; Chantal Humblet; Marie Paule Defresne; Marc Thiry; Francis Frankenne; André Gothot; Peter Carmeliet; Jean-Marie Rakic; Jean-Michel Foidart; Agnès Noël
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

10.  The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.

Authors:  K Bajou; V Masson; R D Gerard; P M Schmitt; V Albert; M Praus; L R Lund; T L Frandsen; N Brunner; K Dano; N E Fusenig; U Weidle; G Carmeliet; D Loskutoff; D Collen; P Carmeliet; J M Foidart; A Noël
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  18 in total

1.  miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.

Authors:  Youngmi Kim; Deokbum Park; Hyuna Kim; Munseon Choi; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

2.  Protease nexin-1 regulates retinal vascular development.

Authors:  Sonia Selbonne; Deborah Francois; William Raoul; Yacine Boulaftali; Florian Sennlaub; Martine Jandrot-Perrus; Marie-Christine Bouton; Véronique Arocas
Journal:  Cell Mol Life Sci       Date:  2015-06-25       Impact factor: 9.261

3.  Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.

Authors:  Deokbum Park; Youngmi Kim; Hyunah Kim; Kyungjong Kim; Yun-Sil Lee; Jongseon Choe; Jang-Hee Hahn; Hansoo Lee; Jongwook Jeon; Chulhee Choi; Young-Myeong Kim; Dooil Jeoung
Journal:  Mol Cells       Date:  2012-05-18       Impact factor: 5.034

4.  TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression.

Authors:  Benaya Rozen-Zvi; Tomoko Hayashida; Susan C Hubchak; Christian Hanna; Leonidas C Platanias; H William Schnaper
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

5.  An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1.

Authors:  Umadevi Subramanian; Ashok Sivapunniyam; Ayyasamy Pudukadu Munusamy; Rajakumar Sundaram
Journal:  Adv Bioinformatics       Date:  2014-12-15

6.  Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis.

Authors:  Maxim D Seferovic; Madhulika B Gupta
Journal:  Dis Markers       Date:  2016-01-19       Impact factor: 3.434

7.  Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes.

Authors:  Anuradha Moirangthem; Banashree Bondhopadhyay; Mala Mukherjee; Arghya Bandyopadhyay; Narendranath Mukherjee; Karabi Konar; Shubham Bhattacharya; Anupam Basu
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

8.  Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy.

Authors:  Zoltán Veréb; Xhevat Lumi; Sofija Andjelic; Mojca Globocnik-Petrovic; Mojca Urbancic; Marko Hawlina; Andrea Facskó; Goran Petrovski
Journal:  Biomed Res Int       Date:  2013-10-01       Impact factor: 3.411

9.  Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1.

Authors:  Sugata Hazra; Valerie Stepps; Ashay D Bhatwadekar; Sergio Caballero; Michael E Boulton; Paul J Higgins; Elena V Nikonova; Carl J Pepine; Catherine Thut; Eva M Finney; David J Stone; Stephen H Bartelmez; Maria B Grant
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

10.  HDAC3 acts as a negative regulator of angiogenesis.

Authors:  Deokbum Park; Hyunmi Park; Youngmi Kim; Hyuna Kim; Dooil Jeoung
Journal:  BMB Rep       Date:  2014-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.